(E)-methyl 4-(3-oxobut-1-enyI)-1H-pyrrole-2-carboxylate | 1190362-71-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: (E)-methyl 4-(3-oxobut-1-enyI)-1H-pyrrole-2-carboxylate
• 英文别名: methyl 4-[(E)-3-oxobut-1-enyl]-1H-pyrrole-2-carboxylate
• CAS: 1190362-71-0
• 化学式: C₁₀H₁₁NO₃
• 分子量: 193.202
• InChiKey: FPBDGBDBAIREKV-ONEGZZNKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  59.2
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] BENZENE DERIVATIVES<br/>[FR] DERIVES DE BENZENE
  申请人：UNIV CARDIFF

  公开号：WO2009125191A1

  公开（公告）日：2009-10-15

  Compounds with the general formula (I): are described wherein R1, R2, R3, R4, R5, Q, T, X, Y and Z are as defined. Compounds according to the invention can display potent inhibition against Hepatitis C Virus (HCV) helicase and potent anti-viral activity against HCV.

  具有一般化学式（I）的化合物被描述，其中R1、R2、R3、R4、R5、Q、T、X、Y和Z如所定义。根据本发明的化合物可以显示出对丙型肝炎病毒（HCV）螺旋酶的强效抑制作用，以及对HCV的强效抗病毒活性。
• Novel cc-1065 Analogs and Their Conjugates
  申请人：Beusker Patrick Henry

  公开号：US20110207767A1

  公开（公告）日：2011-08-25

  This invention relates to novel analogs of the DNA-alkylating agent CC-1065 and to their conjugates. Furthermore this invention concerns intermediates for the preparation of said agents and conjugates. The conjugates are designed to release their (multiple) payload after one or more activation steps and/or at a rate and time span controlled by the conjugate in order to selectively deliver and/or controllably release one or more of said DNA alkylating agents. The agents, conjugates, and intermediates can be used to treat an illness that is characterized by undesired (cell) proliferation. As an example, the agents and the conjugates of this invention may be used to treat a tumor.
• US9815784B2
  申请人：——

  公开号：US9815784B2

  公开（公告）日：2017-11-14
• [EN] NOVEL CC-1065 ANALOGS AND THEIR CONJUGATES<br/>[FR] NOUVEAUX ANALOGUES DE CC-1065 ET LEURS CONJUGUÉS
  申请人：SYNTARGA BV

  公开号：WO2010062171A2

  公开（公告）日：2010-06-03

  This invention relates to novel analogs of the DNA-alkylating agent CC-1065 and to their conjugates. Furthermore this invention concerns intermediates for the preparation of said agents and conjugates. The conjugates are designed to release their (multiple) payload after one or more activation steps and/or at a rate and time span controlled by the conjugate in order to selectively deliver and/or controllably release one or more of said DNA alkylating agents. The agents, conjugates, and intermediates can be used to treat an illness that is characterized by undesired (cell) proliferation. As an example, the agents and the conjugates of this invention may be used to treat a tumor.